Why are labs being put out to tender? Is “creeping” privatisation a problem for pathology, or can it be beneficial?
Horiba Medical has introduced a Quality Accreditation Program (QAP) to assist its customers in reaching and maintaining the required standards for UKAS accreditation.
Shahid Nazir Muhammad, a Specialist Biomedical Scientist, looks at chronic kidney disease and the need for compassionate, nurturing leaders in the field.
What is bioprinting?
A key malaria treatment has failed for the first time in patients being treated in the UK.
Biomedical scientists and IBMS members have been promoting and discussing the profession at debates and talks over recent weeks.
Following February’s feature on planning for major incidents from a mortuary perspective, we look at the issue in relation to pathology.
After numerous newspapers claimed burnt toast could cause cancer, Dr David Robert Grimes peers behind the headlines of health research coverage.
John Windell looks at the religious, moral and scientific principles that have governed research into embryos and asks if a rule that has stood for 30 years is set to change.
Tweets by BiomedScience
Scientists have created a DNA-analysing smartphone attachment, which costs a fraction of lab-based kit.
The European Research Council is set to re-instate the Synergy Grant funding scheme next year. The news follows an assessment of projects funded through pilot calls in 2012 and 2013.
Ortho Clinical Diagnostics has announced that its Ortho Connect V2.0 middleware solution is CE marked and conforms with all EU regulation.
Dawn Alderson gives a guided tour of her veterinary disease surveillance lab, which is “similar to a hospital pathology laboratory”, but with more species to consider.
In the third of our Here to Help series of articles, Jocelyn Pryce, IBMS Head of Registration, discusses the evolving role of CPD Officers.
Journal-based learning (JBL) exercises are a regular feature of CPD coverage in The Biomedical Scientist.